Clomiphene and Anti-Doping: Why the Fertility-Drug Angle Misses the Point
Abhishek Pal, named in India's squad for the Asian Games in the 5,000m and 10,000m, has been dropped by the Athletics Federation of India after an Adverse Analytical Finding (AAF) by NADA for clomiphene. The headlines have largely laid emphasis on one detail, that clomiphene is a female fertility drug. That framing misses the more important point.
Clomiphene is listed under S4, hormone and metabolic modulators, and is banned at all times. In men, it stimulates the body’s own testosterone production, which makes it useful both as a performance aid and as a way to restart the system after a course of anabolic steroids. The female fertility angle is not wrong, it is simply not the reason the substance is on the list.
Where it gets more interesting is contamination. Clomiphene is used in poultry farming to raise egg production, and traces carry through into eggs and chicken. Athletes have returned findings with no explanation other than diet, and laboratory research has since confirmed that the risk is real. WADA addressed this directly in Technical Letter TL26, which sets a minimum reporting level for clomiphene, currently 2 ng/mL. TL26 also draws on research identifying specific metabolites, such as a particular hydroxy-clomiphene isomer excreted at higher relative concentrations weeks after genuine intake, that help distinguish a real dose from contamination through food. In a country where eggs and chicken are staple protein, this is not a small issue.
Two things need to be said clearly, because the rule works in both directions. First, the minimum reporting level (MRL) is a reporting threshold, not a defence. The comment to Article 3.2.1 of the WADA Code is explicit that a concentration below the MRL does not, by itself, excuse an anti-doping rule violation. Second, athletes carry strict liability for whatever is found in their bodies, and a trace still has to be explained on the facts.
What it means is that a low reading of a substance known to enter the food chain is the kind of case the framework was built to examine carefully, rather than treat as a straightforward positive. Where Pal's case lands is for his hearing to decide, however the broader point is that the system exists to catch cheating. It is built to tell the difference between an athlete who knowingly doped and one who accidentally ate the wrong breakfast. This difference is certainly worth understanding before anyone rushes to judge.
